Article
Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
British journal of haematology - 1 Apr 2023
Clark Andrew, Thomas Sally, Hamblin Angela, Talley Polly, Kulasekararaj Austin, Grinfeld Jacob, Speight Beverley, Snape Katie, McVeigh Terri P, Snowden John A
Abstract excerpt
Germline predisposition to haematological cancers is increasingly being recognised. Widespread adoption of high-throughput and whole genome sequencing is identifying large numbers of causative germline mutations. Constitutional pathogenic variants in six genes (DEAD-box helicase 41 [DDX41], ETS variant transcription factor 6 [ETV6], CCAAT enhancer binding protein alpha [CEBPA], RUNX family transcription factor 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
